Orlando– IONICS Mass Spectrometry, a leading developer and manufacturer of high performance triple quads, is launching its latest generation of the 3Q Molecular Analyzers the 3Q Series 200 and 3Q Series 100. “We are committed to responding to customer needs and are expanding the product line to meet the market demand” said Erik Hansen, Vice President Commercial Operations.

The Series 200 instruments (3Q 220 dual source, 3Q 210 single source) are designed for maximum sensitivity for the most demanding assays. The high sensitivity 3Q Series 200`s can run the most challenging assays (ie. quantitation of free testosterone at 1.2 pg/ml or fentanyl to 250 attograms/ml). The 3Q Series 200’s are among the most sensitive instruments available today and are unmatched for robustness and throughput.

The Series 100 instruments (3Q 120 dual source/3Q 110 single source) are designed for routine assays with industry performing sensitivity. The 3Q Series 100 has an extended mass range to 2150 m/z and is the perfect solution for labs performing routine assays and will provide high quality results day-after-day.

IONICS advances can be found throughout the new 3Q Molecular Analyzer Platform. Highlights include:

• Torrent Multi-Option Dual Source™, the only source with the flexibility to be configured for ESI/ESI, ESI/APCI, or APCI/APCI.

• Patented HSID™ (Series 100) and HSID Select™ (Series 200) interfaces (HSID – Hot Source-Induced Desolvation),

• Zero cross-talk collision cell

• Patented Unifield™ Detector.

IONICS innovation is also evident in the vertical footprint, engineered to minimize space requirements. Designed-in serviceability and modularized components ensure maximum uptime, reliability and performance.

“IONICS was set up to create and develop high performance triple quadrupole mass spectrometers. The Series 100 and Series 200 platforms significantly expand our offering providing broader access to IONICS technology and pushing the boundaries of sensitivity and robustness. We are not done yet so stay-tuned” said Dr. Reza Javahery, President and Co-founder IONICS Mass Spectrometry, “We will continue to make advances on sensitivity, throughput and performance”.

IONICS Mass Spectrometry: Founded in 2001, IONICS has built an ever growing IP portfolio while developing performance enhancing solutions for triple quadrupole mass spectrometers. As an innovation leader, IONICS set out to develop and launch a new era of mass spectrometers that built on their initial success. Following the success of the Series A Molecular Analyzer, IONICS has now produced the 3Q Molecular Analyzer Series 100 and Series 200, one of the world’s most advanced family of triple quadrupole systems. Represented directly in North America and Europe and through distributors in the rest of the world, IONICS provides high quality customer service and unmatched support.

Please note – IONICS Mass Spectrometry instruments are for research use only.